The rationale for building a diversified portfolio of broader-spectrum antivirals against RNA viruses with activity spanning multiple genera, entire families or even crossing viral families with activity spanning multiple genera, entire families or even crossing viral families is discussed.
H. Thibaut, Dirk Jochmans, C. Van Dijck et al.· Nature Reviews Microbiology· 0 citations
Findings provide proof-of-concept for AVSBs as a novel strategy to reduce arbovirus transmission by targeting viral replication within the mosquito vector, suggesting that AVSBs could complement existing arbovirus control measures.
Maeva Van Langendonck, A. Rosales-Rosas, Shannan-Leigh Macleod et al.· bioRxiv· 0 citations
iBu TU is highlighted as a promising oral antiviral candidate for treating SARS-CoV-2 infection and significantly reduced viral loads and improved lung health without adverse effects in a Syrian hamster model infected with SARS-CoV-2.
Zhe Chen, F. Amblard, M. Kasthuri et al.· ACS Omega· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.